Close
Nordic 9Nordic 9

Veritas Intercontinental (private company)

Spain veritasint.com
See something wrong or missing? Let us know
Offices:Madrid
Industry:BiotechHealth services
Business model:B2B

Veritas Intercontinental focuses on providing access to advanced preventive medicine through Whole Genome Sequencing, which believes will replace all other genetic tests. Its myGenome signature test is the only test that can provide insights to more than 650 diseases and conditions for healthy individuals.

Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 5.93M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Veritas Intercontinental

Name Criteria
Sweden Monocl
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Sweden iCellate
57%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Germany Atai Life Sciences
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
Sweden Cinclus Pharma
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
Norway Mentis Cura
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
Norway Oncoinvent
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
Ireland ONK Therapeutics
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
United Kingdom Sano Genetics
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
Netherlands Leyden Labs
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
United Kingdom Mogrify
55%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
Top